Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
Decision: Do not wait. I disclose now. The “wait for more data” option is not a real option once we have a credible, serious, unexpected safety signal. Waiting 6 months would mean knowingly continuing to expose 4 million patients to a risk we already know about, while also creating far worse legal, regulatory, and…Read the full answer
48-Hour Action Plan: Patient Safety First, Managed Transparency Second Core Decision (Stated Up Front) We report to regulators immediately—voluntarily—and we disclose on the earnings call. The math is brutal and clear: ~500 patients could develop liver failure over 5 years at current prescribing rates (4M ÷ 8,000).Read the full answer